CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $2,182,000 | -2.5% | 1,059,200 | +1.3% | 0.12% | -6.3% |
Q1 2016 | $2,238,000 | -24.3% | 1,045,700 | +1.8% | 0.13% | -29.4% |
Q4 2015 | $2,957,000 | -34.1% | 1,026,900 | +1.8% | 0.18% | -28.9% |
Q3 2015 | $4,488,000 | -14.5% | 1,008,500 | -1.1% | 0.25% | -4.2% |
Q2 2015 | $5,251,000 | – | 1,019,600 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,464,807 | $14,468,000 | 5.57% |
COURAGE CAPITAL MANAGEMENT LLC | 192,486 | $1,130,000 | 0.86% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 90,455 | $531,000 | 0.07% |
Alambic Investment Management, L.P. | 86,204 | $506,000 | 0.07% |
Kalos Management, Inc. | 30,000 | $164,000 | 0.05% |
Dynamic Technology Lab Private Ltd | 32,394 | $190,000 | 0.03% |
ELLINGTON MANAGEMENT GROUP LLC | 60,600 | $356,000 | 0.03% |
PRELUDE CAPITAL MANAGEMENT, LLC | 55,008 | $323,000 | 0.02% |
REILLY FINANCIAL ADVISORS, LLC | 22,011 | $129,000 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 580,972 | $3,411,000 | 0.02% |